Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange
Transfusion · 2025
DOI: 10.1111/trf.18320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Sirui Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Plasma Exchange, Thrombosis, Hemorrhage, Hemostasis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Whether therapeutic plasma exchange (TPE) results in clinically relevant bleeding or thrombotic events is not well characterized. Study Design and Methods We conducted a single‐institution retrospective cohort study to estimate the incidence of bleeding and thrombotic outcomes of patients treated with TPE from 2017 to 2021. Patients with ≥3 treatment sessions within a 14‐day period were included. Two independent physician reviewers manually reviewed patient charts. We calculated the 30‐day cumulative incidence of bleeding and thrombotic outcomes with 95% confidence intervals (CI). We used a regression model to determine the association between clinical and laboratory features and study outcomes.
Results
The study comprised 145 patients who underwent 176 treatment courses, representing a cumulative total of 890 individual TPE procedures. The cumulative incidence of clinically relevant bleeding (including major bleeding and clinically relevant nonmajor bleeding) was 8.0% (95% CI 4.4%–13.0%), and thrombosis was 4.0% (95% CI 1.6%–8.0%). There was one fatal bleeding event. Older age and chronic kidney disease were associated with odds ratios of 1.08 (95% CI 1.03–1.13, p = .002) and 4.68 (95% CI 1.33–14.90, p = .01), respectively, for bleeding. Patients who received any quantity of fresh frozen plasma as replacement fluid had a bleeding rate of 16.4% compared to 6.6% in patients who did not receive plasma ( p = .05).
Discussion
TPE‐associated bleeding complications occur at a higher rate than previously understood. Further prospective investigations are merited to characterize bleeding risk factors and optimal preventive strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
- Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Section of Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.
- Apheresis Services, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: Sirui Ma
Zitieren
APA
Ma, S., Patell, R., Dodge, L., Ma, S., Knox, M., & Carney, B. J. (2025). Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange. Transfusion. https://doi.org/10.1111/trf.18320
Vancouver
Ma S, Patell R, Dodge L, Ma S, Knox M, Carney BJ. Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange. Transfusion. 2025. doi:10.1111/trf.18320
BibTeX
@article{Ma2025,
author = {Ma, Sirui and Patell, Rushad and Dodge, Laura and Ma, Shengling and Knox, Michelle and Carney, Brian J},
title = {Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18320}
}
EUVIMED